Loading...
PCR logo

PCC Rokita SAWSE:PCR Stock Report

Market Cap zł1.4b
Share Price
zł69.00
zł82.41
16.3% undervalued intrinsic discount
1Y-4.0%
7D0.1%
1D
Portfolio Value
​
View

PCC Rokita SA

WSE:PCR Stock Report

Market Cap: zł1.4b

PCC Rokita (PCR) Stock Overview

Designs, produces, and sells chemical products in Poland, Germany, the European Union, rest of Europe, the United States, Asia, and internationally. More details

PCR fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance0/6
Financial Health6/6
Dividends5/6

Rewards

Trading at 47.3% below our estimate of its fair value

Earnings are forecast to grow 20.36% per year

Risk Analysis

Large one-off items impacting financial results

Profit margins (3.4%) are lower than last year (7.3%)

Unstable dividend track record


PCR Community Fair Values

Create Narrative

See what 13 others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

PCC Rokita SA Competitors

Price History & Performance

Summary of share price highs, lows and changes for PCC Rokita
Historical stock prices
Current Share Pricezł69.00
52 Week Highzł74.40
52 Week Lowzł60.40
Beta0.63
1 Month Change-1.43%
3 Month Change0%
1 Year Change-4.03%
3 Year Change-31.00%
5 Year Change-10.39%
Change since IPO108.08%

Recent News & Updates

Recent updates

Analysis Article • Apr 29

Does PCC Rokita (WSE:PCR) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • May 30

Is There An Opportunity With PCC Rokita SA's (WSE:PCR) 36% Undervaluation?

Key Insights Using the 2 Stage Free Cash Flow to Equity, PCC Rokita fair value estimate is zł138 PCC Rokita is...
Analysis Article • Aug 24

Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Apr 29

PCC Rokita's (WSE:PCR) Shareholders Will Receive A Bigger Dividend Than Last Year

PCC Rokita SA ( WSE:PCR ) will increase its dividend on the 10th of May to PLN21.57, which is 63% higher than last...
Analysis Article • Jan 18

Is PCC Rokita (WSE:PCR) A Risky Investment?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Apr 16

PCC Rokita (WSE:PCR) Is Increasing Its Dividend To zł13.23

The board of PCC Rokita SA ( WSE:PCR ) has announced that the dividend on 5th of May will be increased to zł13.23...
Analysis Article • Mar 19

Why We Like The Returns At PCC Rokita (WSE:PCR)

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...
Analysis Article • Jan 25

What Is PCC Rokita SA's (WSE:PCR) Share Price Doing?

While PCC Rokita SA ( WSE:PCR ) might not be the most widely known stock at the moment, it received a lot of attention...
Analysis Article • Sep 01

We Like These Underlying Return On Capital Trends At PCC Rokita (WSE:PCR)

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
Analysis Article • Jun 14

Why PCC Rokita SA (WSE:PCR) Could Be Worth Watching

PCC Rokita SA ( WSE:PCR ), is not the largest company out there, but it led the WSE gainers with a relatively large...
Analysis Article • May 18

Are PCC Rokita SA (WSE:PCR) Investors Paying Above The Intrinsic Value?

In this article we are going to estimate the intrinsic value of PCC Rokita SA ( WSE:PCR ) by taking the expected future...
Analysis Article • Apr 13

Returns On Capital At PCC Rokita (WSE:PCR) Have Hit The Brakes

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Analysis Article • Mar 23

Why PCC Rokita's (WSE:PCR) Earnings Are Better Than They Seem

PCC Rokita SA ( WSE:PCR ) announced a healthy earnings result recently, and the market rewarded it with a strong stock...
Analysis Article • Mar 09

PCC Rokita SA's (WSE:PCR) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?

Most readers would already be aware that PCC Rokita's (WSE:PCR) stock increased significantly by 25% over the past...
Analysis Article • Feb 19

Looking For Steady Income For Your Dividend Portfolio? Is PCC Rokita SA (WSE:PCR) A Good Fit?

Today we'll take a closer look at PCC Rokita SA ( WSE:PCR ) from a dividend investor's perspective. Owning a strong...
Analysis Article • Feb 04

What Does PCC Rokita SA's (WSE:PCR) Share Price Indicate?

While PCC Rokita SA ( WSE:PCR ) might not be the most widely known stock at the moment, it saw a significant share...
Analysis Article • Jan 15

Is PCC Rokita (WSE:PCR) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Dec 30

Should We Be Excited About The Trends Of Returns At PCC Rokita (WSE:PCR)?

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...
Analysis Article • Dec 17

Reflecting on PCC Rokita's (WSE:PCR) Share Price Returns Over The Last Three Years

PCC Rokita SA ( WSE:PCR ) shareholders should be happy to see the share price up 13% in the last month. But that cannot...
Analysis Article • Dec 03

PCC Rokita SA's (WSE:PCR) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

PCC Rokita's (WSE:PCR) stock is up by a considerable 8.0% over the past month. However, we wonder if the company's...
Analysis Article • Nov 20

Are Dividend Investors Getting More Than They Bargained For With PCC Rokita SA's (WSE:PCR) Dividend?

Today we'll take a closer look at PCC Rokita SA (WSE:PCR) from a dividend investor's perspective. Owning a strong...

Shareholder Returns

PCRPL ChemicalsPL Market
7D0.1%-0.2%0.3%
1Y-4.0%-2.5%28.3%

Return vs Industry: PCR underperformed the Polish Chemicals industry which returned -1.1% over the past year.

Return vs Market: PCR underperformed the Polish Market which returned 29.4% over the past year.

Price Volatility

Is PCR's price volatile compared to industry and market?
PCR volatility
PCR Average Weekly Movement3.4%
Chemicals Industry Average Movement4.2%
Market Average Movement5.3%
10% most volatile stocks in PL Market11.1%
10% least volatile stocks in PL Market3.1%

Stable Share Price: PCR has not had significant price volatility in the past 3 months compared to the Polish market.

Volatility Over Time: PCR's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20021,370Wieslaw Klimkowskiwww.pcc.rokita.pl

PCC Rokita SA designs, produces, and sells chemical products in Poland, Germany, the European Union, rest of Europe, the United States, Asia, and internationally. It operates through five segments: Polyurethanes, Chlorine Derivatives, Other Chemical Activities, Energy, and Other Activities. The Polyurethanes segment produces polyols, polyurethane systems, and prepolymers; and flexible foams, rigid foams, coatings, elastomers, adhesives, impregnations, and other products.

PCC Rokita SA Fundamentals Summary

How do PCC Rokita's earnings and revenue compare to its market cap?
PCR fundamental statistics
Market capzł1.40b
Earnings (TTM)zł61.48m
Revenue (TTM)zł1.80b
22.7x
P/E Ratio
0.8x
P/S Ratio

Is PCR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PCR income statement (TTM)
Revenuezł1.80b
Cost of Revenuezł1.50b
Gross Profitzł302.78m
Other Expenseszł241.30m
Earningszł61.48m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

Aug 19, 2026

Earnings per share (EPS)3.03
Gross Margin16.81%
Net Profit Margin3.41%
Debt/Equity Ratio32.6%

How did PCR perform over the long term?

See historical performance and comparison

Dividends

7.3%
Current Dividend Yield
69%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/03 03:28
End of Day Share Price 2026/06/03 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PCC Rokita SA is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Henning EsskuchenErste Group Bank AG
Jakub SzkopekErste Group Bank AG
Adam MilewiczPKO BP Securities